Skip to main content

Table 4 The age of hereditary cancer diagnostics and cancer-related death by population screening data.

From: Population screening for hereditary and familial cancer syndromes in Valka district of Latvia

Syndrome

Age of diagnosis

Age of death

 

Interval (years)

Mean (95% CIM)

Interval (years)

Mean (95% CIM)

HBC/g1

40 - 55

47.5 (37.1 - 57.8)

50 - 60

54.7 (50.0 - 59.4)

HBC1/g2

20 - 70

38.0 (36.2 - 39.7)

26 - 78

44.7 (41.7 - 47.7)

HBC2/g2

25 - 82

51.8 (48.9 - 54.6)

25 - 66

60.9 (56.7 - 65.1)

HBOC/g1

34 - 82

61.0 (46.9 - 75.0)

58 - 85

71.4 (54.9 - 87.9)

HBOC1/g2

40 - 60

48.8 (44.2 - 53.3)

47 - 69

54.3 (42.3 - 66.3)

HBOC2/g2

18 - 86

56.6 (51.8 - 61.4)

23 - 87

66.1 (61.2 - 71.0)

HOC/g1

34 - 70

49.7 (4.0 - 95.4)

72

72

HOC/g2

45 - 70

54.2 (46.4 - 61.9)

47 - 72

57.2 (50.1 - 64.3)

HNPCC/g1

30 - 77

54.2 (50.2 - 58.2)

28 - 89

61.7 (54.2 - 69.2)

   CRC

36 - 77

59.3 (53.8 - 64.8)

28 - 89

61.5 (52.9 - 70.0)

   E

30 - 65

48.4 (43.4 - 53.4)

37 - 72

NA

HNPCC/g2

27 - 82

53.7 (49.1 - 58.3)

28 - 88

55.5 (49.5 - 61.5)

   CRC

28 - 82

55.2 (49.1 - 61.3)

32 - 88

56.7 (49.9 - 63.5)

   E

27 - 72

50.5 (43.0 - 58.0)

28 - 73

51.2 (33.1 - 69.3)

FCC/g2

41 - 89

72.0 (67.3 - 76.7)

52 - 90

76.3 (73.1 - 79.5)

HEC/g1

40 - 75

52.1 (47.2 - 57.0)

44 - 76

57.7 (49.6 - 65.8)

HEC/g2

30 - 81

48.5 (44.4 - 52.6)

35 - 87

58.7 (53.6 - 63.8)

FEC/g1

52 - 90

66.3 (63.0 - 69.6)

54 - 91

71.7 (68.6 - 74.8)

FEC1/g2

60 - 78

67.0 (53.1 - 80.9)

65 - 86

79.2 (69.0 - 84.4)

FEC2/g2

26 - 82

57.6 (49.9 - 65.3)

26 - 83

63.3 (54.7 - 71.9)

FLC/g1

35 - 78

56.0 (53.0 - 59.0)

36 - 79

57.1 (54.1 - 60.1)

FLC/g2

18 - 90

58.5 (56.1 - 60.9)

13 - 90

61.2 (59.1 - 63.3)

FLC/g3

18 - 90

57.9 (55.9 - 59.9)

13 - 90

61.2 (58.5 - 62.1)

HGC/g1

30 - 83

56.9 (53.4 - 66.3)

30 - 90

58.3 (55.3 - 61.3)

HGC/g2

34 - 95

62.5 (60.1 - 64.8)

37 - 96

65.6 (63.4 - 67.6)

HPC/g1

70 - 74

72.0 (67.0 - 76.9)

72

NA

HPC/g2

35 - 75

56.8 (52.8 - 60.8)

37 - 80

59.7 (54.6 - 64.8)

HPC/g3

35 - 75

57.7 (53.3 - 62.1)

37 - 80

60.7 (55.0 - 66.4)

FBlaC/g1

60 - 75

67.5 (53.7 - 81.3)

65 - 75

70.3 (65.6 - 75.0)

FBlaC/g2

61 - 87

71.8 (67.3 - 76.3)

72 - 92

79.3 (74.1 - 84.5)

FBlaC/g3

60 - 87

70.7 (66.7 - 74.7)

65 - 92

75.7 (71.6 - 79.8)

FHemT/g1

45 - 61

50.7 (28.4 - 73.0)

46 - 50

48.0 (22.6 - 73.4)

FHemT/g2

3 - 88

47.1 (37.5 - 56.7)

4 - 90

49.9 (39.7 - 60.1)

FHemT/g3

3 - 88

47.5 (38.9 - 56.1)

4 - 86

49.8 (40.5 - 59.1)

FPanC/g1

51 - 72

61.6 (57.3 - 65.9)

51 - 83

63.4 (58.2 - 68.6)

FBT/g1

59 - 60

59.7 (58.3 - 61.1)

50 - 65

59.7 (54.3 - 65.1)

FBT/g2

2 - 77

41.8 (32.0 - 51.6)

2 - 75

45.2 (35.9 - 54.5)

FBT/g3

2 - 77

43.9 (35.0 - 52.8)

2 - 77

47.8 (39.7 - 55.9)

  1. CIM, confidence interval for the mean; CRC, colorectal cancer; E, endometrial cancer; NA, not applicable.